U.S. Markets close in 3 hrs

ADM Tronics Unlimited, Inc. (ADMT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1050+0.0020 (+1.94%)
As of 11:50AM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1030
Open0.1050
BidN/A x N/A
AskN/A x N/A
Day's Range0.1050 - 0.1075
52 Week Range0.0800 - 0.1800
Volume67,190
Avg. Volume65,518
Market Cap7.097M
Beta (5Y Monthly)-0.23
PE Ratio (TTM)N/A
EPS (TTM)-0.0030
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ADM Tronics Secures Infectious Disease Prevention Training Certification
    GlobeNewswire

    ADM Tronics Secures Infectious Disease Prevention Training Certification

    Northvale, NJ, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Tronics Unlimited, Inc. (OTCQB – ADMT) has secured the “Infectious Disease Prevention Training Certification” from the New Jersey Business and Industry Association (“NJBIA”) by creating and formally adopting a disease prevention plan and detailed procedures, meeting guidelines set forth by The World Health Organization, Center for Diseases Control and the Occupational Safety and Health Administration. ADMT participated in workshops and training conducted by NJBIA required to secure the Certification for designation as a “Certified Site.” Throughout the pandemic, ADMT implemented aggressive steps to minimize disruption of operations including having Essential Manufacturer exemption from statewide shutdowns and encompassing safety guidelines in ADMT’s operations. This allowed continued research, development and manufacturing operations throughout the COVID-19 pandemic. “Securing this Certification is another facet of our commitment to minimize the impact of the pandemic on our Company,” stated Andre’ DiMino, President of ADMT. “The health of our employees, their families and our community is paramount, as we continue to exercise caution to help avoid spread of the disease, while at the same time, maintaining our operations. Technologies we develop and manufacture are needed for the medical and other industries we serve. We strive to maintain our ability to produce these for our loyal customers, and the patients and users needing them.” ADMT specializes in design, development and manufacturing of diagnostic and therapeutic electronic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services. ADMT welcomes inquiries for its medical device services via the ADMT website – www.admtronics.com. To receive email updates directly from the Company, fill in the form at the bottom of the page at this link: https://admtronics.com/investor-relations/ About ADMT ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly Formulations from its headquarters, laboratories, and FDA-Registered medical device manufacturing operations. ADMT’s multi-disciplinary team of engineers, researchers, and technologists utilize advanced technology infrastructure for R&D and commercialization of diversified technologies. admtronics.com. Except for historical information contained herein, the matters set forth in this news release are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT’s SEC filings, news releases, and other communications. The Company assumes no obligation to update the information contained in this news release. Andre DiMino 201-767-6040 andre@admtronics.com

  • ACCESSWIRE

    ADM Tronics Reports Third Quarter of Fiscal Year 2021 Results

    NORTHVALE, NJ / ACCESSWIRE / February 12, 2021 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its third fiscal quarter ended December 31, .

  • GlobeNewswire

    ADM Tronics Secures USPTO Registration for "Engineering Health"

    Northvale, NJ, Jan. 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- ADM Tronics Unlimited, Inc. (OTCQB – ADMT) has received Official Notice from the U.S. Patent and Trademark Office (USPTO) that its filing for protection for “Engineering Health” has been accepted, entitling the Company to use the registered trademark symbol in the U.S. for its engineering activities "in the field of Medical Devices.” This complements ADMT’s expansion of engineering development activities for its pipeline of proprietary therapeutic medical device technologies, as well as its medical device contract engineering services for customers. “This newly registered service mark perfectly brands our research and development engineering activities for our own medical technologies and for the engineering services we provide to our customers,” stated Andre DiMino, President of ADMT. “Engineering Health exemplifies what we do each and every day to create, innovate and commercialize therapeutic and diagnostic medical device technologies to improve the health and well-being of the people who will use these technologies to deal with medical conditions and diseases.” The USPTO registration of the Engineering Health registered service mark authorizes ADMT to use the “®” designation with the mark to identify such official registration. ADMT specializes in electronic medical device design, development and manufacturing of diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ. ADMT has extensive experience in the development of all FDA classes of medical devices with a particular emphasis on electronic therapeutic modalities. The Company has a pipeline of several proprietary medical devices currently in various stages of development. In addition to its own medical technology developments, the Company is a one-stop source for complete design, engineering, regulatory and manufacturing services, specifically related to US and international medical device development. Its capability in bringing a medical device from the conceptual stage, through design, development and regulatory stages into production, all in-house, differentiates ADMT from firms supplying only portions of those services. ADMT welcomes inquiries for its medical device services by contacting sales@admtronics.com or via the ADMT website – www.admtronics.com. About ADMT ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and, Eco-Friendly Formulations from its headquarters, laboratories, and FDA-Registered medical device manufacturing operations. ADMT’s multi-disciplinary team of engineers, researchers, and technologists utilize advanced technology infrastructure for R&D and commercialization of diversified technologies. admtronics.com. Except for historical information contained herein, the matters set forth in this news release are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT’s SEC filings, news releases, and other communications. The Company assumes no obligation to update the information contained in this news release. Andre DiMino201-767-6040